The resignation of Tennessee Corrections Commissioner Frank Strada on Saturday is being framed as accountability for a single botched execution. That framing is convenient. It is also wrong. Strada’s departure after the failed lethal injection of Christa Pike — the only woman on Tennessee’s death row — does not represent a system correcting itself. It represents a system that has perfected the art of moving failure across state lines until it lands in a headline.
What Happened
Strada was appointed by Governor Bill Lee in 2023 with a resume that read like a corrections executive’s greatest hits: nearly three decades at the Federal Bureau of Prisons, then a senior role in Arizona’s Department of Corrections, Rehabilitation and Reentry. Lee’s office praised Strada’s “extensive corrections management and law enforcement experience.” What the announcement omitted — and what Lee’s vetting either missed or dismissed — was the paper trail Strada left in Arizona. Between 2022 and 2023, Arizona carried out three executions after an eight-year moratorium. All three encountered problems establishing IV lines. The state’s governor ordered an independent review of execution protocols. That review was announced weeks after Lee promoted Strada to Tennessee’s top corrections post.
The details of Arizona’s internal reckoning only surfaced later, in a 2023 sworn declaration by Ryan Thornell, who succeeded Strada as Arizona’s corrections director. Thornell testified he was “unable to locate sufficient documentation” about execution procedures under the previous administration. He identified “several critical issues”: inadequate expertise, untested lethal injection drugs, and IV team procedures that existed largely as institutional folklore rather than written protocol. Most damning: Thornell could not find documentation identifying the pharmacist who compounded the lethal drugs. The prior deputy director — Strada — had been the main point of contact with that pharmacist but recorded nothing. The drug supply’s efficacy “couldn’t be guaranteed” and needed testing before use. Tennessee hired Strada anyway.
Why It Matters
The Strada case illuminates a structural defect in how American states manage capital punishment: there is no national licensing, no centralized database of execution outcomes, and no mechanism to flag officials who preside over repeated procedural failures. Each state’s corrections department operates as a sovereign fiefdom. When a commissioner moves from Arizona to Tennessee, their institutional knowledge — including their failures — does not follow them in any formal sense. It follows them only if journalists or defense attorneys dig it up.
This is not abstract. The Eighth Amendment prohibits cruel and unusual punishment, but the Supreme Court has repeatedly held that the Constitution does not guarantee a painless execution — only that states not inflict “superadded” pain through deliberate indifference or incompetence. In Baze v. Rees (2008) and Glossip v. Gross (2015), the Court placed the burden on inmates to prove a “substantial risk of serious harm” from a state’s protocol. That standard assumes states are operating in good faith with competent personnel. Strada’s trajectory suggests that assumption is unfounded. A corrections chief who oversaw three consecutive IV failures in Arizona — and left no documentation of drug sourcing or team procedures — was entrusted to implement Tennessee’s revised protocol. The Christa Pike execution was the predictable result.
The drug supply chain problem is its own crisis. Since 2010, European manufacturers have blocked export of execution drugs to the U.S., forcing states into shadow markets: compounding pharmacies, unregulated suppliers, and secrecy statutes that shield procurement from public records laws. Arizona’s inability to identify its own pharmacist under Strada’s watch is not an anomaly. It is the predictable outcome of a system that treats execution logistics as state secrets. Tennessee’s own secrecy law, enacted in 2013 and expanded since, makes it a felony to disclose the identity of drug suppliers or execution team members. That law protected Strada’s operation from scrutiny until it failed in public view.
There is also the political dimension. Governor Lee, a Republican with national ambitions, appointed Strada as part of a “law and order” platform that includes expanding Tennessee’s death penalty statutes. In 2024, Lee signed legislation adding firing squad as an execution method — a tacit admission that lethal injection is becoming untenable. Strada’s resignation allows Lee to claim accountability without addressing the policy framework that made Strada’s hire possible. The governor’s office has not answered whether it knew of the Arizona IV failures before appointing Strada, or whether it conducted an independent review of his execution record.
Historical Context
The pattern of officials rotating through death penalty states despite troubled records is not new. In the 1990s and 2000s, wardens and execution team members moved between Texas, Virginia, and Oklahoma — states that accounted for the majority of U.S. executions — carrying informal knowledge of “how to get it done.” But the modern era is different. The drug shortage has made executions technically complex in ways that require pharmaceutical expertise, not just procedural familiarity. The IV failures in Arizona and Tennessee are not matters of nerves or haste. They reflect a fundamental mismatch: corrections staff are being asked to perform medical procedures — venous cutdowns, central line placement — for which they are not trained, using drugs of uncertain provenance and potency.
Consider the parallel with Oklahoma. After the botched execution of Clayton Lockett in 2014 — where an IV infiltrated and Lockett writhed for 43 minutes before dying of a heart attack — Oklahoma paused executions for six years. When it resumed, it hired a private consulting firm to redesign its protocol. The firm’s principal had previously worked for a pharmaceutical company that opposed the use of its drugs in executions. The conflict of interest went unreported for months. The lesson: states are improvising in the dark, often with consultants and officials whose incentives are misaligned with constitutional compliance.
What to Watch
Three developments will determine whether Strada’s resignation changes anything. First, Tennessee’s legislative response. Will the General Assembly amend the secrecy statute to allow independent review of drug procurement and execution team qualifications? A bill to that effect died in committee in 2025. The Pike execution may revive it — or may prompt lawmakers to double down on firing squad as a workaround that avoids the drug problem entirely.
Second, the federal dimension. President Donald Trump’s Department of Justice has signaled renewed support for federal executions, which resumed in 2020 after a 17-year hiatus. The Federal Bureau of Prisons — where Strada spent 30 years — operates under its own protocol, but it shares the same drug supply constraints. If the Trump administration pushes to accelerate federal executions, the same personnel and procurement failures will migrate to the federal system. The BOP’s execution team is drawn from the same pool of state corrections veterans.
Third, litigation. Christa Pike’s legal team will almost certainly file a new Eighth Amendment challenge arguing that Tennessee’s protocol, as implemented under Strada, creates an unconstitutional risk of severe pain. The Supreme Court’s current conservative majority has been skeptical of such challenges, but the factual record here — documented IV failures across two states under the same official — is stronger than in most recent cases. A district court evidentiary hearing could force disclosure of Tennessee’s drug testing records, IV team training logs, and Strada’s communications with Arizona officials. That disclosure is what the secrecy statute was designed to prevent.
Key Takeaway
The Strada affair is not a personnel scandal. It is a systems failure. America’s death penalty apparatus runs on institutional amnesia: states hire officials who presided over botched executions elsewhere because there is no mechanism to track, share, or penalize that history. Secrecy laws protect the supply chain from scrutiny. Political incentives reward “tough on crime” appointments over technical competence. Until Congress or the courts impose a national standard for execution protocol transparency — including mandatory reporting of complications, drug testing data, and personnel qualifications — the next Frank Strada is already in the pipeline. The only variable is which state’s headline he will generate next.
